Safety, tolerability, and immunogenicity of the novel antituberculous vaccine RUTI: randomized, placebo-controlled phase II clinical trial in patients with latent tuberculosis infection
Nell, Andre S, D'lom, Eva, Bouic, Patrick, Sabaté, Montserrat, Bosser, Ramon, Picas, Jordi, Amat, Mercè, Churchyard, Gavin, Cardona, Pere-Joan
Published in PloS one (26.02.2014)
Published in PloS one (26.02.2014)
Get full text
Journal Article
Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI: Randomized, Placebo-Controlled Phase II Clinical Trial in Patients with Latent Tuberculosis Infection: e89612
Nell, Andre S, D'lom, Eva, Bouic, Patrick, Sabate, Montserrat, Bosser, Ramon, Picas, Jordi, Amat, Merce, Churchyard, Gavin, Cardona, Pere-Joan
Published in PloS one (01.02.2014)
Published in PloS one (01.02.2014)
Get full text
Journal Article